ArticleFrontiers in pharmacology2023

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score.

Jochen G Mainz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.